Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy

Stopped early · Phase 2

Conditions studied: Acute Myeloid Leukemia

In brief

This randomized phase II trial studies how well a gluten free diet works in diminishing side effects in patients with acute myeloid leukemia undergoing induction chemotherapy. A gluten free diet may result in less intestinal side effects and blood infections during the induction chemotherapy compared to a standard diet.

Key facts

Study ID

NCT03108911

Run by

Rutgers, The State University of New Jersey

People needed

1

Starts

2017-07-27

Expected to finish

2017-11-14

Last updated by the study team

2017-11-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing AML induction chemotherapy with an anthracycline + cytarabine-based chemotherapy regimen
• No history of celiac disease or non-celiac gluten sensitivity
• No grade 3 or 4 gastrointestinal (GI) toxicity at time of initial screening
• No documented bacteremia at time of initial screening
• Eastern Cooperative Oncology Group (ECOG) performance status 0, 1 or 2 at time of initial screening

You may not qualify if…

• Pregnant women

Where it is running

• Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.